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1. Introduction 
Previous published results [l-8 ] proved that both 
aniline and benzene are enzymatically hydroxymethy 
lated by liver microsomal and bacterial systems and 
furthermore, the aryl hydroxymethyl compounds 
form the hydroxylated end products via a hydroxyla- 
tive-dehydroxymethylation pathway. More recently 
it was shown that Escherichia coli also hydroxymethy 
lates L-phenylalanine to form p-hydroxymethyl-l- 
phenylalanine [9]. It had also been proven that the 
microorganism forms L-tyrosine via the hydroxyla- 
tive-dehydroxymethylation reaction and that the or- 
ganism also forms L-phenylalanine from the aryl 
hydroxymethyl amino acid [8,9]. 
It is the purpose of this publication to show that 
E. coli and Gram positive nutritionally fastidious 
microorganisms metabolize p-hydroxymkhyl-l- 
phenylalanine to either phenylalanine or tyrosine. 
The utilization of the hydroxymethyl amino acid to 
form tyrosine represents a hydroxylative-dehydroxy 
methylation reaction. However the rat is incapable 
of metabolizing the amino acid (p-hydroxymethyl- 
Cphenylalanine). 
t Resent address is: Department of Biochemie, Faculte des 
Sciences, Universite Laval, Quebec Ice, Canada. 
2. Materials and methods 
The synthesis of the aryl amino acid, p-hydroxy- 
methyl-L-phenylalanine and the purification of the 
tritiated compound were previously described [8]. 
The specific activity of [3H]p-hydroxymethyl-L- 
phenylalanine was diluted to contain 6 pCi per 1 .O ml 
that contained 7.0 E.IM of the amino acid. This solu- 
tion 0.5 ml (lo6 cpm) was injected intraperitoneally 
into rats. 
Four male albino rats of the Wistar strain (140- 
150 g) were used for each experiment. Each determi- 
nation was done in duplicate for each sample of or- 
gan, protein, urine, CO* and plasma. 
Uniformly labeled L- [’ 4C]phenylalanine (Amers- 
ham-Searle), 1 mg in 0.5 ml, (8.6 X 10’ cpm) was 
injected i.p. into rats. 
Determinations of the expired labeled COZ , of the 
excretion of label in the urine and of the incorpora- 
tion of label into organ and plasma proteins were 
performed by published techniques [lo] . Liquid 
scintillation counting of all samples were performed 
by the techniques previously described [lo] . 
The following microorganisms were utilized in 
these studies: Escherichia coli F ATCC* 9723 (the 
* American Type Culture Collection. 
North-HoIland hblishing Company - Amsterakm 159 
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phenylalanineless mutant); Leuconostoc mesenteroi- 
des ATCC 8042; Lactobacillus casei ATCC 7469; 
Lactobacillus leichmannii ATCC 7830. The medium 
used to determine the utilization of hydroxymethyl- 
L-phenylalanine in lieu of phenylalanine by E. coli 
F was that described by Anderson [12]. 
The medium used to determine the utilization of 
the aryl hydroxymethyl amino acid by L. mesente- 
roides was that described by Steele et al. [ 131 deleting 
either L-phenylalanine or L-tyrosine. Similar techni- 
ques were used with L. casei [ 141 and L. leichman- 
nii [ 1.51. All incubations were carried out at 37°C for 
48-72 hr. 
3. Results and discussion 
3.1. Retention of [3 H]p-hydroxymethyl-L-phenylala- 
nine in organs of the rat 
Studies on the metabolism of [3H]p-hydroxyme- 
thyl-L-phenylalanine are summarized in table 1. The 
retention of label by rat organs, and the loss of the 
tritiated compound from that organ varies consider- 
ably. Two hours after injection the kidney shows 
greater than five times the count of the liver per gram 
of tissue, and the pancreas contained greater than 
three times the number of counts found in the liver. 
However, 24 hr after the injection the pancreas 
contained 46% of the counts shown after 2 hr, where- 
as the loss of label by both the kidney and liver was 
more substantial from the second to the twenty- 
Table 1 
Retention of radioactivity in organs and plasma and 
excretion of radioactivity in urine 
2 hr 24 hr 
Liver* 2495 f 33 940 +-61 
Pancreas* 89.50 + 170 4160 +62 
Kidney* 13,970 f 280 2562 r 43 
Plasma** 1898 + 74 995 f 81 
Urine+ 18.0 ?: 4.5 42.5 + 1.5 
* Counts per minute per g tissue, mean S.D. 
** Counts per minute per ml of plasma. 
t Cumulative percentage of administrated ose excreted. 
160 
fourth hours; after 24 hr, the kidney contained 18% 
of the label shown at 2 hr, and the liver, 38% of 
label found at 2 hr. The maintenance of over 50% of 
the label in the plasma after 24 hr was probably due 
to leaching of the label from the organs. After 24 
hr over 40% of the injected label was excreted into 
the urine. 
3.2. Studies on the incorporation [3H]hydroxymethyl- 
L-phenylalanine in rat tissue proteins 
The retention of tritium label in the organs varied 
considerably (table l), however the counted radioac- 
tivity in these organs did not represent amino acid 
incorporation into tissues proteins as determined by 
the technique of Godin and Dolan [lo] . Two hours 
after injection the counts present in tissue proteins 
(0.2 to 2.0 counts/min/mg protein) were of the order 
of O.l-0.5% of those obtained upon injection of 
L- [‘*Cl phenylalanine. It was shown earlier than when 
[’ 4 C]p-fluorophenylalanine was injected into rats, 
54% of the radioactivity found in proteins (39- 114 
counts/min/mg protein) was present as [’ 4 C] tyrosine 
[ 1 l] . If the p-hydroxymethyl-L-phenylalanine was 
transformed into phenylalanine or tyrosine by the rat, 
much more radioactivity would be found in the rat 
tissue proteins. Furthermore, the in vivo incorporation 
of [I4 C] phenylalanine or [“Cl tyrosine was not 
affected by the simultaneous injection of unlabelled 
p-hydroxymethyl-L-phenylalanine. The aryl hydroxy- 
methyl amino acid does not inhibit protein synthesis 
whereas fl-thienyl-alanine does. In addition when 
fi-thienylalanine or 2-amino-3-phenylbutanoic acid 
were injected simultaneously with [‘4C]phenylalani- 
ne, there was an increase excretion of I4 C in the 
respiratory CO* [lo]. When p-hydroxymethyl-l- 
phenylalanine (15 mg per 100 g) was injected simul- 
taneously with radioactive phenylalanine or radioac- 
tive tyrosine no changes were observed in the rate of 
excretion and in the quantity of I4 C excreted in the 
CO2 during the first 6 hr following the injection. 
3.3. Utilization of p-hydroxymethyl-L-phenylalanine 
by microorganisms 
The utilization of p-hydroxymethyl-l-phenylalani- 
ne (L-HMPhe) by the phenylalanineless mutant of 
E. coli F was described previously [8] but the data 
was not quantitated. However publication [S] did 
prove that the wild strain of E. coli (ATCC 9723) 
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converted L-HMPhe into tyrosine, in the presence of 
the tyrosine inhibitor, 2 aminotyrosine. This metabo- 
lic conversion represented a hydroxylative-dehydroxy- 
methylation reaction. L-HMPhe was shown to be 2% 
as effective as L-tyrosine under the conditions report- 
ed. Therefore, nutritionally fastidious Gram positive 
organisms were studied to determine whether they 
were also capable of utilizing the L-isomer of HMPhe 
in lieu of phenylalanine and tyrosine. The results 
presented in table 2 conclusively demonstrate that 
E coli, L. mesenteroides, L. cusei and L. leichmannii 
are each capable of metabolizing L-HMPhe to (a) 
phenylalanine by the cleavage of the C-C bond be- 
tween the phenyl ring and the hydroxymethyl side 
chain, and (b) to tyrosine by the hydroxylative- 
dehydroxymethylation reaction, via a direct hydroxyl 
replacement of the side chain hydroxymethyl group. 
The inability of these organisms to utilize phenylala- 
nine per se to satisfy the tyrosine requirement is evi- 
dence that the enzyme phenylalanine hydroxylase is 
absent from these microorganisms. However, Guroff 
and Ito [16] reported that a species ofPseudomonas 
does possess the phenylalanine hydroxylase. 
It is interesting to note that the least nutritionally 
complex organism (E coli) utilized L-HMPhe ten 
times more efficiently than the nutritionally complex 
microorganisms, L. casei and L. leichmannii, whereas 
the organism L. mesenteroides of intermediate nutri- 
tional complexity utilized L-HMPhe four times more 
effectively than the former two organisms. Further- 
more, each species of organism utilized L-HMPhe to 
form either phenylalanine or tyrosine to essentially 
Table 2 
Microbial utilization of p-hydroxymethyl-L-phenylalanine 
to L-phenylalanine and L-tyrosine 
Organism Percent conversion of p-hydroxy- 
methyl-L-phenylalanine to 
Phenylalanine Tyrosine 
E. coli 1.60 2.00* 
L. mesenteroides 0.80 0.80 
L casei 0.18 0.20 
L leichmannii 0.20 0.20 
* Data reported by Smith and Sloane [ 81. 
Table 3 
Reversal of growth inhibition of 
p-hydroxymethyl-D,L-phenylalanine 
by the L-isomer 
Absorbance at 
600 nm 
25 hr 42 hr 
1. Basal medium 0 0 
2. 1 + 2 pmoles D,L-HMPhe 0 0 
3. 1 + 4 pmoles D,L-HMPhe 0 0 
4. 1 + 4 pmoles L-HMPhe 0.19 - 
5. 1 + 4 r.rmoles L-HMPhe + 4 pmoles 
D,L-HMPhe 0.18 - 
6. 1 + 4 ltmoles L-HMPhe + 2 pmoles 
D,L-HMPhe 0.17 - 
7. 1 + 2 rmoles L-HMPhe _ 0.50 
E. coli F was used in these studies; the cultures were incuba- 
ted at 37°C as previously described 181. 
the same degree; these data (table 2) demonstrate that 
the progressive loss of enzymatic function is the same 
for each enzyme within each species. 
The inability of the D,L-isomer to support the 
growth of these microorganisms may be due to the 
interference of the uptake of the L-isomer by the 
D-isomer. The addition of 2 pmoles of the L-isomer 
to the medium that continued 4 pmoles of the 
D,L-isomer allowed a growth response by I?. coli 
after 2.5 hr incubation that was maximal for this level 
of L-HMPhe. After 42 hr incubation the organisms 
did not show a growth response to the D,L-isomer. Si- 
milar results were obtained with L. mesenteroides, 
L. casei, and L. leichmannii, utilizing 10 ymoles of 
the D,L-compound and 10 pmoles of the L-isomer. 
The data with E coli are presented in table 3. 
The data presented in this paper demonstrate that 
the rat is incapable of metabolizing L-HMPhe to 
phenylalanine or tyrosine, whereas microorganisms 
metabolize L-HMPhe to (a) phenylalanine and (b) 
tyrosine by a pathway that does not involve hydroxy 
lation of phenylalanine per se. Thus these pathways 
are not unique to E. coli (a question posed by Um- 
barger [17]) but these pathways do not appear to be 
significant ones since the hydroxymethylation of 
Lphenylalanine by E. coli occurs to only a limited 
extent [9 ] . 
The concomitant hydroxylative rupture of a 
161 
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C-C bond between the phenyl ring and the side 
chain carbon atom has also been shown to occur in 
the formation of catechol from salicylic acid [ 181 and 
in the biosynthesis of coenzyme Q [ 191. 
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